-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCLETIS PHARMA INC.: TOPLINE HUMAN PHARMACOKINETIC DATA FROM THIS STUDY IS EXPECTED BY END OF 2026

Reuters·11/17/2026 09:12:15